The need for biomarkers in amyotrophic lateral sclerosis drug development.
Wagner
Kathryn R
KR
D000690:Amyotrophic Lateral Sclerosis / Q000134:cerebrospinal fluid*; D015415:Biomarkers / Q000134:cerebrospinal fluid; D015195:Drug Design; D006801:Humans
D015415:Biomarkers